Unravelling the Smokers' Paradox: Cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y12 inhibitors

Paul A. Gurbel, Brian A. Baker, William L. Bailey, Kevin P. Bliden, Udaya S. Tantry

Research output: Contribution to journalLetterpeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Unravelling the Smokers' Paradox: Cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y12 inhibitors'. Together they form a unique fingerprint.